VitaNova Life Sciences VNOV
OTC VNOV
$1.38 +0.00 (+0.00%)
At close: Sep 16, 2026 · 4:00 PM EDT

VitaNova Life Sciences (VNOV) Cash from Discontinued Operations (2017 - 2019)

VitaNova Life Sciences' (VNOV) quarterly Cash from Discontinued Operations came in at -$50.0 in Q2 2019, up 99.72% on a QoQ basis from -$17649.0 in Q4 2017.

Analysis

VitaNova Life Sciences (VNOV) Cash from Discontinued Operations (2017 - 2019) Analysis & Trends

VitaNova Life Sciences has disclosed Cash from Discontinued Operations across 2 years of filings, most recently posting -$50.0 for Q2 2019.

  • Cash from Discontinued Operations for Q2 2019 came in at -$50.0, changed N/A year-over-year; the trailing twelve-month figure through Apr 2020 was -$50.0 (changed N/A YoY), and the FY2019 annual result was $57054.0, up 840.96% from the prior year.
  • Cash from Discontinued Operations for Q2 2019 stood at -$50.0, up from -$17649.0 in the prior quarter.
  • Across five years, Cash from Discontinued Operations topped out at -$50.0 in Q2 2019 and bottomed at -$17649.0 in Q4 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discontinued Operations (Qtr)
1 Accenture 120.96 Bn 111.91 Bn 6.13 Bn -
2 UL Solutions 12.94 Bn 12.53 Bn 417.00 Mn -
3 Gartner 11.74 Bn 10.25 Bn 1.19 Bn -
4 Booz Allen Hamilton Holding 9.28 Bn 8.74 Bn 1.46 Bn -
5 Tetra Tech 9.14 Bn 8.91 Bn 243.21 Mn -
6 Genpact 5.74 Bn 5.22 Bn 490.34 Mn -
7 Grand Canyon Education 3.97 Bn 3.69 Bn 204.08 Mn -
8 Fti Consulting 3.91 Bn 3.74 Bn 316.27 Mn -
9 Korn Ferry 3.90 Bn 3.09 Bn 681.29 Mn -
10 VitaNova Life Sciences 11.51 Mn 9.90 Mn 30,521.00 -
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2019 -50.00
Oct 31, 2017 -17,649.00